Terms: = Pancreatic cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Treatment
6 results:
1. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
2. Early Recurrence in Resected Gallbladder Carcinoma: Clinical Impact and Its Preoperative Predictive Score.
Shimizu Y; Ashida R; Sugiura T; Okamura Y; Ohgi K; Yamada M; Otsuka S; Aramaki T; Notsu A; Uesaka K
Ann Surg Oncol; 2022 Sep; 29(9):5447-5457. PubMed ID: 35666409
[TBL] [Abstract] [Full Text] [Related]
3. Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells.
Wang K; Li L; Jin J; An Y; Wang Z; Zhou S; Zhang J; Abuduaini B; Cheng C; Li N
J Diabetes Complications; 2022 Jun; 36(6):108159. PubMed ID: 35210136
[TBL] [Abstract] [Full Text] [Related]
4. Predicting unintentional weight loss in patients with gastrointestinal cancer.
Yoon SL; Kim JA; Kelly DL; Lyon D; George TJ
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):526-535. PubMed ID: 30834673
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of gemcitabine combined with targeted agent therapy versus gemcitabine monotherapy in the management of advanced pancreatic cancer.
Li Q; Yuan Z; Yan H; Wen Z; Zhang R; Cao B
Clin Ther; 2014 Jul; 36(7):1054-63. PubMed ID: 24986485
[TBL] [Abstract] [Full Text] [Related]
6. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
[TBL] [Abstract] [Full Text] [Related]
